Literature DB >> 8079112

Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients.

H I Maaroos1, M Kekki, T Vorobjova, V Salupere, P Sipponen.   

Abstract

BACKGROUND: We describe here our observations on colonization of the gastric mucosa by Helicobacter pylori in a long-term follow-up of 25 patients with gastric ulcer (GU).
METHODS: All patients were followed-up endoscopically for more than 10 years (mean, 16 years) and endoscopically verified to have GU in the angular or corpus area of the stomach. None had received treatment with H2 blockers or omeprazole or had undergone any maintenance therapy or surgery. On the basis of the endoscopic findings on the activity of GU at follow-up endoscopies, the patients were divided into a group of subjects with 'low risk' of recurrence (15 patients who either had no (7 patients) or only a single recurrence (8 patients) at the first follow-up endoscopy but not thereafter) and into those with a 'high risk' of recurrence (10 patients who had at least 2 episodes of recurrence at follow-up endoscopies).
RESULTS: A severe bilateral (antrum and corpus) colonization of the gastric mucosa by H. pylori at the first re-examination (1-6 years after the initial diagnosis of GU) was the most important characteristic feature in the patients with high risk of recurrence as compared with those with low risk. In the course of the follow-up, colonization of the corpus mucosa by H. pylori remained rather unchanged in both high- and low-risk subjects but decreased in grade in antrum particularly in those with low risk (no bacteria at the last endoscopy in 13 of 16 low-risk patients and in 2 of 8 high-risk patients). In both low- and high-risk groups corpus gastritis developed progressively into atrophic gastritis (11 of 25 patients had severe corpus atrophy at the last endoscopy). On the other hand, antral gastritis showed a tendency to heal (13 of 24 patients had normal or only slightly gastric antrum at the last endoscopy).
CONCLUSIONS: The observations indicate that the H. pylori plays a role in and associates closely with the long-term course of angular or corpus GU disease and is related to the tendency of these ulcers to recur.

Entities:  

Mesh:

Year:  1994        PMID: 8079112     DOI: 10.3109/00365529409092468

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis.

Authors:  Masaaki Kodama; Kazunari Murakami; Ryugo Sato; Tadayoshi Okimoto; Akira Nishizono; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Influence of bile reflux and Helicobacter pylori infection on gastritis in the remnant gastric mucosa after distal gastrectomy.

Authors:  Hisanori Abe; Kazunari Murakami; Shunzo Satoh; Ryugo Sato; Masaaki Kodama; Tsuyoshi Arita; Toshio Fujioka
Journal:  J Gastroenterol       Date:  2005-06       Impact factor: 7.527

Review 3.  Therapy and prevention of gastric ulcer.

Authors:  C B Lamers; I Biemond; A A Masclee; R A Veenendaal
Journal:  Yale J Biol Med       Date:  1996 May-Jun

Review 4.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II.

Authors:  Sharad Sharma; Ahmet Gurakar; Cemalettin Camci; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2008-12-17       Impact factor: 3.199

5.  Expression of mutant type-p53 products in H pylori-associated chronic gastritis.

Authors:  Masaaki Kodama; Kazunari Murakami; Tadayoshi Okimoto; Ryugo Sato; Koichiro Watanabe; Toshio Fujioka
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 6.  Chronic gastritis.

Authors:  Pentti Sipponen; Heidi-Ingrid Maaroos
Journal:  Scand J Gastroenterol       Date:  2015-04-22       Impact factor: 2.423

7.  Efficacy and safety of Zuojin Pill for chronic gastritis: Protocol for a systematic review of randomized controlled trials.

Authors:  Jianglong Shi; Liyun Liu; Jian Li; Xiaoju Ma; Hairong Qiu; Tao Shen
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.